508 related articles for article (PubMed ID: 326957)
1. In vivo immune response suppression by the supernatant from concanavalin A-activated spleen cells.
Reinertsen JL; Steinberg AD
J Immunol; 1977 Jul; 119(1):217-22. PubMed ID: 326957
[TBL] [Abstract][Full Text] [Related]
2. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. II. Lack of antigenic specificity and immunogenetic requirements of allogeneic suppressive factor (ASF).
Yonkosky D; Buffett RF; Bennett M
J Immunol; 1976 Jun; 116(6):1695-703. PubMed ID: 58047
[TBL] [Abstract][Full Text] [Related]
3. Specific susceptibility of sensitized (memory) B cells to suppression and antigenic alteration by murine leukemia virus.
Cerny J; Waner EB
J Immunol; 1975 Feb; 114(2 Pt 1):571-80. PubMed ID: 164504
[TBL] [Abstract][Full Text] [Related]
4. Suppression of immune responses to sheep erythrocytes by the lymphokine soluble immune response suppressor (SIRS) in vivo.
Schnaper HW; Aune TM
J Immunol; 1986 Aug; 137(3):863-7. PubMed ID: 3088113
[TBL] [Abstract][Full Text] [Related]
5. Induction of the rat in vitro plaque-forming response to sheep erythrocytes by a soluble factor(s) derived from concanavalin A-activated rat T lymphocytes.
Teodorczyk-Injeyan JA; Falk RE
Folia Biol (Praha); 1982; 28(4):243-54. PubMed ID: 6754468
[TBL] [Abstract][Full Text] [Related]
6. Regulation of alloantigen-induced cytotoxic responses by concanavalin A-activated lymphoid cells: suppression by antigen elimination.
Kastner DL; Rich RR
J Immunol; 1978 Nov; 121(5):1732-7. PubMed ID: 712063
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of murine plaque-forming cell responses in vivo by ribavirin.
Peavy DL; Powers CN; Knight V
J Immunol; 1981 Mar; 126(3):861-4. PubMed ID: 7007503
[TBL] [Abstract][Full Text] [Related]
8. Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.
Tadakuma T; Kühner AL; Rich RR; David JR; Pierce CW
J Immunol; 1976 Jul; 117(1):323-30. PubMed ID: 6595
[TBL] [Abstract][Full Text] [Related]
9. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide. II. Ability of suppressor T cells to act on both B cells and amplified T cells to limit the magnitude of the antibody response.
Markham RB; Reed ND; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
J Immunol; 1977 Sep; 119(3):1163-8. PubMed ID: 19533
[TBL] [Abstract][Full Text] [Related]
10. The effect of staphylococcal enterotoxins on the primary in vitro immune response.
Smith BG; Johnson HM
J Immunol; 1975 Aug; 115(2):575-8. PubMed ID: 1097520
[TBL] [Abstract][Full Text] [Related]
11. The potentiality of antibody-producing cells. I Bispecific cell occurrence in double stimulated cultures of syngeneic or allogeneic spleen cells of the mouse.
Couderc J; Bleux C; Birrien JL; Liacopoulos P
Immunology; 1975 Oct; 29(4):653-64. PubMed ID: 1102444
[TBL] [Abstract][Full Text] [Related]
12. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
Fenton MR; Havas HF
J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the suppressive effect of interferon on antibody synthesis in vivo.
Brodeur BR; Merigan TC
J Immunol; 1975 Apr; 114(4):1323-8. PubMed ID: 163863
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the antibody response by a formamidine pesticide: dependence on the route of exposure.
Shopp GM; McCay JA; Holsapple MP
J Toxicol Environ Health; 1985; 15(2):293-304. PubMed ID: 3859671
[TBL] [Abstract][Full Text] [Related]
15. The enhancement of the immune response by pain stimulation in mice. I. The enhancement effect on PFC production via sympathetic nervous system in vivo and in vitro.
Fujiwara R; Orita K
J Immunol; 1987 Jun; 138(11):3699-703. PubMed ID: 3035011
[TBL] [Abstract][Full Text] [Related]
16. Modulation of mouse anti-SRBC antibody responses by placental extracts. II. Antigen specificity and regulatory role of B and T cell populations affected by two distinct placental fractions.
Bobé P; Kanellopoulos-Langevin C; Bleux C; Voisin GA
J Immunol; 1986 Jan; 136(2):574-81. PubMed ID: 2416814
[TBL] [Abstract][Full Text] [Related]
17. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide I. Comparison of the suppression induced by con A and low dose paralysis.
Markham RB; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
J Immunol; 1977 Mar; 118(3):952-6. PubMed ID: 15032
[TBL] [Abstract][Full Text] [Related]
18. Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells.
Douglas GN; Rubin AS
Immunology; 1977 May; 32(5):669-79. PubMed ID: 324897
[TBL] [Abstract][Full Text] [Related]
19. Effect of thyroxine on the immune response of mice in vivo and in vitro.
Chen Y
Immunol Commun; 1980; 9(3):260-76. PubMed ID: 6995277
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression by spleen cells from Moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response.
Cerny J; Stiller RA
J Immunol; 1975 Oct; 115(4):943-9. PubMed ID: 170339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
